Castle Biosciences, Inc. Common Stock CSTL

$29.62 -3.04% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 FORM 4 2026-08-06 View →
4 FORM 4 2026-08-06 View →
4 FORM 4 2026-08-05 View →
4 FORM 4 2026-08-04 View →
4 FORM 4 2026-08-04 View →
10-Q 10-Q 2026-07-30 View →
8-K 8-K 2026-07-30 View →
4 FORM 4 2026-07-29 View →
4 FORM 4 2026-07-16 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-07-06 View →
4 FORM 4 2026-06-18 View →
4 FORM 4 2026-06-17 View →
4 FORM 4 2026-06-03 View →
4 FORM 4 2026-06-01 View →
4 FORM 4 2026-06-01 View →
4 FORM 4 2026-06-01 View →
4 FORM 4 2026-06-01 View →
4 FORM 4 2026-06-01 View →
4 FORM 4 2026-06-01 View →
4 FORM 4 2026-06-01 View →
8-K 8-K 2026-05-29 View →
4 FORM 4 2026-05-27 View →
4 FORM 4 2026-05-27 View →
4 FORM 4 2026-05-27 View →
4 FORM 4 2026-05-27 View →
4 FORM 4 2026-05-27 View →
4 FORM 4 2026-05-27 View →
4 FORM 4 2026-05-27 View →
4 FORM 4 2026-05-26 View →
4 FORM 4 2026-05-22 View →
4 FORM 4 2026-05-11 View →
10-Q 10-Q 2026-05-06 View →
8-K 8-K 2026-05-06 View →
4 FORM 4 2026-04-23 View →
4 FORM 4 2026-04-08 View →
DEF 14A DEF 14A 2026-04-08 View →
4 FORM 4 2026-03-30 View →
4 FORM 4 2026-03-30 View →
4 FORM 4 2026-03-19 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$29.62
Market Cap
$960.17 million
52-Week Range
$14.59 – $44.28
Average Volume
428K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.